{"transactions":[{"id":781379,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":47770,"kind":"person","name":"Walsh Patrick D","position":1,"cik":"0001720568","reported_name":"Walsh Patrick D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-14T00:22:10.000Z","date":"2026-05-13","kind":"sale","planned":false,"acquired":false,"shares":10000,"price":80.63,"value":806300.0,"ownership":{"direct":true},"balance_after":38432,"source":{"system":"sec-edgar","filing":"0001720568-26-000005","document":"wk-form4_1778718127.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000172056826000005/wk-form4_1778718127.xml","form_type":"4"}},{"id":781378,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":47770,"kind":"person","name":"Walsh Patrick D","position":1,"cik":"0001720568","reported_name":"Walsh Patrick D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-14T00:22:10.000Z","date":"2026-05-11","kind":"sale","planned":false,"acquired":false,"shares":3973,"price":80.75,"value":320819.75,"ownership":{"direct":true},"balance_after":48432,"source":{"system":"sec-edgar","filing":"0001720568-26-000005","document":"wk-form4_1778718127.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000172056826000005/wk-form4_1778718127.xml","form_type":"4"}},{"id":870195,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":47770,"kind":"person","name":"Walsh Patrick D","position":1,"cik":"0001720568","reported_name":"Walsh Patrick D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-03T23:01:04.000Z","date":"2026-03-03","kind":"sale","planned":false,"acquired":false,"shares":6000,"price":74.23,"value":445380.0,"ownership":{"direct":true},"balance_after":52405,"source":{"system":"sec-edgar","filing":"0001720568-26-000002","document":"wk-form4_1772578861.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000172056826000002/wk-form4_1772578861.xml","form_type":"4"}},{"id":998212,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":47770,"kind":"person","name":"Walsh Patrick D","position":1,"cik":"0001720568","reported_name":"Walsh Patrick D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-17T23:01:38.000Z","date":"2025-11-13","kind":"gift","planned":false,"acquired":false,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction reported on this Form 4 reflects a bona fide gift of Company's common stock to a donor-advised fund (\"DAF\") for charitable purposes. The Reporting Person retains no beneficial ownership or control over the donated securities following the contribution."}],"balance_after":58405,"source":{"system":"sec-edgar","filing":"0001720568-25-000007","document":"wk-form4_1763420495.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000172056825000007/wk-form4_1763420495.xml","form_type":"4"}},{"id":998211,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":47770,"kind":"person","name":"Walsh Patrick D","position":1,"cik":"0001720568","reported_name":"Walsh Patrick D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-17T23:01:38.000Z","date":"2025-11-13","kind":"sale","planned":false,"acquired":false,"shares":8643,"price":86.88,"value":750903.84,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were sold in multiple trades at prices ranging from $86.15 to $87.80. The price reported above reflects the weighted average sales price."}],"balance_after":61405,"source":{"system":"sec-edgar","filing":"0001720568-25-000007","document":"wk-form4_1763420495.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000172056825000007/wk-form4_1763420495.xml","form_type":"4"}},{"id":1064498,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":47770,"kind":"person","name":"Walsh Patrick D","position":1,"cik":"0001720568","reported_name":"Walsh Patrick D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-08-18T20:34:32.000Z","date":"2025-08-15","kind":"sale","planned":false,"acquired":false,"shares":9000,"price":89.05,"value":801450.0,"ownership":{"direct":true},"balance_after":70048,"source":{"system":"sec-edgar","filing":"0001720568-25-000004","document":"wk-form4_1755549267.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000172056825000004/wk-form4_1755549267.xml","form_type":"4"}},{"id":1134018,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":47770,"kind":"person","name":"Walsh Patrick D","position":1,"cik":"0001720568","reported_name":"Walsh Patrick D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-27T22:15:33.000Z","date":"2025-05-22","kind":"grant","planned":false,"acquired":true,"shares":4336,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a restricted stock award that will vest in full on May 22, 2026."}],"balance_after":79048,"source":{"system":"sec-edgar","filing":"0001720568-25-000002","document":"wk-form4_1748384127.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000172056825000002/wk-form4_1748384127.xml","form_type":"4"}},{"id":1504254,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":47770,"kind":"person","name":"Walsh Patrick D","position":1,"cik":"0001720568","reported_name":"Walsh Patrick D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-24T00:03:53.000Z","date":"2024-05-21","kind":"grant","planned":false,"acquired":true,"shares":4410,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a restricted stock award that will vest in full on May 21, 2025."}],"balance_after":74712,"source":{"system":"sec-edgar","filing":"0001720568-24-000003","document":"wk-form4_1716509024.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000172056824000003/wk-form4_1716509024.xml","form_type":"4"}},{"id":1880230,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":47770,"kind":"person","name":"Walsh Patrick D","position":1,"cik":"0001720568","reported_name":"Walsh Patrick D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-24T20:34:51.000Z","date":"2023-05-23","kind":"grant","planned":false,"acquired":true,"shares":6865,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a restricted stock award that will vest in full on May 23, 2024."}],"balance_after":70302,"source":{"system":"sec-edgar","filing":"0001104659-23-064158","document":"tm2316872-5_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000110465923064158/tm2316872-5_4seq1.xml","form_type":"4"}},{"id":2288141,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":47770,"kind":"person","name":"Walsh Patrick D","position":1,"cik":"0001720568","reported_name":"Walsh Patrick D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-29T22:24:22.000Z","date":"2022-04-27","kind":"grant","acquired":true,"shares":10049,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a restricted stock award that will vest in full on April 27, 2023."}],"balance_after":63437,"source":{"system":"sec-edgar","filing":"0001415889-22-004393","document":"form4-04292022_030412.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000141588922004393/form4-04292022_030412.xml","form_type":"4"}},{"id":2322100,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":47770,"kind":"person","name":"Walsh Patrick D","position":1,"cik":"0001720568","reported_name":"Walsh Patrick D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-03-22T21:39:14.000Z","date":"2022-03-21","kind":"purchase","acquired":true,"shares":5000,"price":27.7588,"value":138794.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were acquired in multiple trades at prices ranging from $27.475 to $27.90. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":53388,"source":{"system":"sec-edgar","filing":"0001415889-22-003268","document":"form4-03222022_020356.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000141588922003268/form4-03222022_020356.xml","form_type":"4"}},{"id":2678163,"issuer":{"id":6447,"kind":"organization","name":"LIFECORE BIOMEDICAL, INC. \\DE\\"},"owners":[{"id":47770,"kind":"person","name":"Walsh Patrick D","position":1,"cik":"0001720568","reported_name":"Walsh Patrick D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2021-06-09T00:06:05.000Z","date":"2021-06-04","kind":"grant","acquired":true,"shares":7059,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Restricted Stock Units will vest on the 1st anniversary of the grant date and will be automatically settled in shares of common stock."}],"balance_after":7059,"derivative":{"exercise_date":"2022-06-04","underlying":"Common Stock","underlying_shares":7059},"source":{"system":"sec-edgar","filing":"0001593968-21-001574","document":"primary_01.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1005286/000159396821001574/primary_01.xml","form_type":"4"}},{"id":2742345,"issuer":{"id":6447,"kind":"organization","name":"LIFECORE BIOMEDICAL, INC. \\DE\\"},"owners":[{"id":47770,"kind":"person","name":"Walsh Patrick D","position":1,"cik":"0001720568","reported_name":"Walsh Patrick D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-22T20:10:07.000Z","date":"2021-04-20","kind":"purchase","acquired":true,"shares":10000,"price":11.26,"value":112600.0,"ownership":{"direct":true},"balance_after":40000,"source":{"system":"sec-edgar","filing":"0001593968-21-001158","document":"primary_01.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1005286/000159396821001158/primary_01.xml","form_type":"4"}},{"id":2772310,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":47770,"kind":"person","name":"Walsh Patrick D","position":1,"cik":"0001720568","reported_name":"Walsh Patrick D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-25T20:34:49.000Z","date":"2021-03-23","kind":"grant","acquired":true,"shares":9292,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a restricted stock award that will vest in full on March 23, 2022."}],"balance_after":48388,"source":{"system":"sec-edgar","filing":"0001415889-21-001653","document":"form4-03252021_010333.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000141588921001653/form4-03252021_010333.xml","form_type":"4"}},{"id":2783726,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":47770,"kind":"person","name":"Walsh Patrick D","position":1,"cik":"0001720568","reported_name":"Walsh Patrick D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-17T23:55:50.000Z","date":"2021-03-15","kind":"purchase","acquired":true,"shares":4000,"price":32.8888,"value":131555.2,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were acquired in multiple trades at prices ranging from $32.645 to $33.2699. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":39096,"source":{"system":"sec-edgar","filing":"0001415889-21-001560","document":"form4-03172021_040314.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000141588921001560/form4-03172021_040314.xml","form_type":"4"}},{"id":2943674,"issuer":{"id":83494,"kind":"organization","name":"Avid Bioservices, Inc.","symbol":"CDMO"},"owners":[{"id":47770,"kind":"person","name":"Walsh Patrick D","position":1,"cik":"0001720568","reported_name":"Walsh Patrick D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2020-12-16T20:00:58.000Z","date":"2020-12-14","kind":"grant","acquired":true,"shares":2379,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit (\"RSU\") represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's Common Stock."},{"field":"shares","element":"transactionShares","label":"F1","text":"Annual grant of equity awards pursuant to the Issuer's non-employee director compensation program."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"100% of each equity award granted to the reporting person shall vest on December 14, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"100% of each equity award granted to the reporting person shall vest on December 14, 2021."}],"balance_after":2379,"derivative":{"exercise_date":"2021-12-14","underlying":"Common Stock","underlying_shares":2379},"source":{"system":"sec-edgar","filing":"0001683168-20-004319","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/704562/000168316820004319/ownership.xml","form_type":"4"}},{"id":2943673,"issuer":{"id":83494,"kind":"organization","name":"Avid Bioservices, Inc.","symbol":"CDMO"},"owners":[{"id":47770,"kind":"person","name":"Walsh Patrick D","position":1,"cik":"0001720568","reported_name":"Walsh Patrick D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-12-16T20:00:58.000Z","date":"2020-12-14","kind":"grant","acquired":true,"shares":10030,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Annual grant of equity awards pursuant to the Issuer's non-employee director compensation program."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"100% of each equity award granted to the reporting person shall vest on December 14, 2021."}],"balance_after":124305,"derivative":{"exercise_price":10.72,"exercise_date":"2021-12-14","expiration_date":"2027-12-14","underlying":"Common Stock","underlying_shares":10030},"source":{"system":"sec-edgar","filing":"0001683168-20-004319","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/704562/000168316820004319/ownership.xml","form_type":"4"}},{"id":2984492,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":47770,"kind":"person","name":"Walsh Patrick D","position":1,"cik":"0001720568","reported_name":"Walsh Patrick D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-11-12T22:11:51.000Z","date":"2020-11-09","kind":"purchase","acquired":true,"shares":5000,"price":25.96,"value":129800.0,"ownership":{"direct":true},"balance_after":35096,"source":{"system":"sec-edgar","filing":"0001415889-20-002608","document":"form4-11122020_021137.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000141588920002608/form4-11122020_021137.xml","form_type":"4"}},{"id":3005690,"issuer":{"id":6447,"kind":"organization","name":"LIFECORE BIOMEDICAL, INC. \\DE\\"},"owners":[{"id":47770,"kind":"person","name":"Walsh Patrick D","position":1,"cik":"0001720568","reported_name":"Walsh Patrick D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2020-10-16T21:15:35.000Z","date":"2020-10-14","kind":"grant","acquired":true,"shares":5398,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Restricted Stock Units will vest on the 1st anniversary of the grant date and will be automatically settled in shares of common stock."}],"balance_after":5398,"derivative":{"exercise_date":"2021-10-14","underlying":"Common Stock","underlying_shares":5398},"source":{"system":"sec-edgar","filing":"0001593968-20-002054","document":"primary_01.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1005286/000159396820002054/primary_01.xml","form_type":"4"}},{"id":3060727,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":47770,"kind":"person","name":"Walsh Patrick D","position":1,"cik":"0001720568","reported_name":"Walsh Patrick D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN, INTERIM PRES. & CEO"}}],"security":"Common Stock","published_at":"2020-08-12T20:18:14.000Z","date":"2020-08-10","kind":"purchase","acquired":true,"shares":3000,"price":30.89,"value":92670.0,"ownership":{"direct":true},"balance_after":30096,"source":{"system":"sec-edgar","filing":"0001415889-20-002087","document":"form4-08122020_010803.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000141588920002087/form4-08122020_010803.xml","form_type":"4"}},{"id":3060726,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":47770,"kind":"person","name":"Walsh Patrick D","position":1,"cik":"0001720568","reported_name":"Walsh Patrick D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN, INTERIM PRES. & CEO"}}],"security":"Common Stock","published_at":"2020-08-12T20:18:14.000Z","date":"2020-08-10","kind":"purchase","acquired":true,"shares":4000,"price":30.98,"value":123920.0,"ownership":{"direct":true},"balance_after":27096,"source":{"system":"sec-edgar","filing":"0001415889-20-002087","document":"form4-08122020_010803.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000141588920002087/form4-08122020_010803.xml","form_type":"4"}},{"id":3060725,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":47770,"kind":"person","name":"Walsh Patrick D","position":1,"cik":"0001720568","reported_name":"Walsh Patrick D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHAIRMAN, INTERIM PRES. & CEO"}}],"security":"Common Stock","published_at":"2020-08-12T20:18:14.000Z","date":"2020-08-10","kind":"purchase","acquired":true,"shares":3000,"price":30.4,"value":91200.0,"ownership":{"direct":true},"balance_after":23096,"source":{"system":"sec-edgar","filing":"0001415889-20-002087","document":"form4-08122020_010803.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000141588920002087/form4-08122020_010803.xml","form_type":"4"}},{"id":3151333,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":47770,"kind":"person","name":"Walsh Patrick D","position":1,"cik":"0001720568","reported_name":"Walsh Patrick D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim President and CEO"}}],"security":"Common Stock","published_at":"2020-05-13T20:31:20.000Z","date":"2020-05-11","kind":"grant","acquired":true,"shares":7050,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The restricted stock was granted to the Reporting Person in connection with his commencement as interim President and Chief Executive Officer of the issuer. The restricted stock vests on the earlier of (i) May 11, 2021 or (ii) the termination of the Reporting Person's service as interim President and Chief Executive Officer, except in connection with a \"for cause\" termination."}],"balance_after":20096,"source":{"system":"sec-edgar","filing":"0001104659-20-060890","document":"tm2019363d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000110465920060890/tm2019363d1_4.xml","form_type":"4"}},{"id":3177392,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":47770,"kind":"person","name":"Walsh Patrick D","position":1,"cik":"0001720568","reported_name":"Walsh Patrick D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-04-14T20:33:19.000Z","date":"2020-04-10","kind":"grant","acquired":true,"shares":9255,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The restricted stock vests on April 10, 2021."}],"balance_after":13046,"source":{"system":"sec-edgar","filing":"0001104659-20-046395","document":"tm2015775d4_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000110465920046395/tm2015775d4_form4.xml","form_type":"4"}},{"id":3195684,"issuer":{"id":83494,"kind":"organization","name":"Avid Bioservices, Inc.","symbol":"CDMO"},"owners":[{"id":47770,"kind":"person","name":"Walsh Patrick D","position":1,"cik":"0001720568","reported_name":"Walsh Patrick D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.001 par value","published_at":"2020-03-25T13:09:41.000Z","date":"2020-03-23","kind":"purchase","acquired":true,"shares":30000,"price":3.22,"value":96600.0,"ownership":{"direct":false,"nature":"By Diligence Team LLC Pension Account"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported for this transaction is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $3.15 to $3.27, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1)."}],"balance_after":30000,"source":{"system":"sec-edgar","filing":"0001683168-20-000942","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/704562/000168316820000942/ownership.xml","form_type":"4"}},{"id":3312898,"issuer":{"id":83494,"kind":"organization","name":"Avid Bioservices, Inc.","symbol":"CDMO"},"owners":[{"id":47770,"kind":"person","name":"Walsh Patrick D","position":1,"cik":"0001720568","reported_name":"Walsh Patrick D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-01-13T20:36:05.000Z","date":"2020-01-09","kind":"grant","acquired":true,"shares":19675,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Annual grant of stock options pursuant to the Issuer's non-employee director compensation program."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option fully vests one year from the date of grant."}],"balance_after":114275,"derivative":{"exercise_price":6.87,"exercise_date":"2021-01-09","expiration_date":"2027-01-09","underlying":"Common Stock","underlying_shares":19675},"source":{"system":"sec-edgar","filing":"0001683168-20-000109","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/704562/000168316820000109/ownership.xml","form_type":"4"}},{"id":3572735,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":47770,"kind":"person","name":"Walsh Patrick D","position":1,"cik":"0001720568","reported_name":"Walsh Patrick D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2019-04-01T20:02:52.000Z","date":"2019-03-28","kind":"grant","acquired":true,"shares":2409,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The restricted stock and stock options vest on March 28, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock and stock options vest on March 28, 2020."}],"balance_after":2409,"derivative":{"exercise_price":66.39,"expiration_date":"2029-03-27","underlying":"Common Stock","underlying_shares":2409},"source":{"system":"sec-edgar","filing":"0001144204-19-017416","document":"tv517663_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000114420419017416/tv517663_4.xml","form_type":"4"}},{"id":3572734,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":47770,"kind":"person","name":"Walsh Patrick D","position":1,"cik":"0001720568","reported_name":"Walsh Patrick D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-04-01T20:02:52.000Z","date":"2019-03-28","kind":"grant","acquired":true,"shares":1991,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The restricted stock and stock options vest on March 28, 2020."}],"balance_after":3791,"source":{"system":"sec-edgar","filing":"0001144204-19-017416","document":"tv517663_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000114420419017416/tv517663_4.xml","form_type":"4"}},{"id":3728259,"issuer":{"id":83494,"kind":"organization","name":"Avid Bioservices, Inc.","symbol":"CDMO"},"owners":[{"id":47770,"kind":"person","name":"Walsh Patrick D","position":1,"cik":"0001720568","reported_name":"Walsh Patrick D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-12-18T20:26:27.000Z","date":"2018-12-14","kind":"grant","acquired":true,"shares":19600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option fully vests one year from the date of grant."}],"balance_after":94600,"derivative":{"exercise_price":5.22,"exercise_date":"2019-12-14","expiration_date":"2025-12-14","underlying":"Common Stock","underlying_shares":19600},"source":{"system":"sec-edgar","filing":"0001683168-18-003748","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/704562/000168316818003748/ownership.xml","form_type":"4"}},{"id":3900494,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":47770,"kind":"person","name":"Walsh Patrick D","position":1,"cik":"0001720568","reported_name":"Walsh Patrick D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2018-06-08T20:02:49.000Z","date":"2018-06-06","kind":"grant","acquired":true,"shares":2225,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The restricted stock and stock options are subject to vesting, and 50% of the restricted stock and stock options vest on May 17, 2019, and the remaining 50% of the restricted stock and stock options vest on May 17, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock and stock options are subject to vesting, and 50% of the restricted stock and stock options vest on May 17, 2019, and the remaining 50% of the restricted stock and stock options vest on May 17, 2020."}],"balance_after":2225,"derivative":{"exercise_price":65.86,"expiration_date":"2028-06-05","underlying":"Common Stock","underlying_shares":2225},"source":{"system":"sec-edgar","filing":"0001144204-18-033532","document":"tv496176_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000114420418033532/tv496176_4.xml","form_type":"4"}},{"id":3900493,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":47770,"kind":"person","name":"Walsh Patrick D","position":1,"cik":"0001720568","reported_name":"Walsh Patrick D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-08T20:02:49.000Z","date":"2018-06-06","kind":"grant","acquired":true,"shares":1800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The restricted stock and stock options are subject to vesting, and 50% of the restricted stock and stock options vest on May 17, 2019, and the remaining 50% of the restricted stock and stock options vest on May 17, 2020."}],"balance_after":1800,"source":{"system":"sec-edgar","filing":"0001144204-18-033532","document":"tv496176_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000114420418033532/tv496176_4.xml","form_type":"4"}},{"id":4181537,"issuer":{"id":83494,"kind":"organization","name":"Avid Bioservices, Inc.","symbol":"CDMO"},"owners":[{"id":47770,"kind":"person","name":"Walsh Patrick D","position":1,"cik":"0001720568","reported_name":"Walsh Patrick D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2017-10-24T17:23:38.000Z","date":"2017-10-20","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in thirty-six (36) equal monthly installments over a three (3) year period beginning November 20, 2017 and each month thereafter until fully-vested."}],"balance_after":75000,"derivative":{"exercise_price":4.08,"exercise_date":"2017-11-20","expiration_date":"2027-10-20","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001683168-17-002736","document":"walsh_f4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/704562/000168316817002736/walsh_f4.xml","form_type":"4"}}]}